Advair Diskus: Phase IV data

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K.
Product: Advair Diskus ( Seretide - EU) salmeterol/fluticasone propionate
Business: Inflammation
Molecular target: Adrenergic receptor beta 2 (

Read the full 240 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE